| ■ 영문 제목 : Global Central Nervous System (CNS) Stimulant Drugs Market 2023-2027
|
 | ■ 상품코드 : IRTNTR72695-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 2월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아 태평양, 기타 지역
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,375,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Technavio사의 본 연구 보고서에 따르면 세계의 중추 신경계 (CNS) 자극제 시장 규모가 2022 년과 2027 년 사이에 6,486.71 백만 달러에 이르며, 예측 기간 동안 연평균 5.8 % 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 중추 신경계 (CNS) 자극제 시장에 대해 조사 및 분석하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, Five Force 분석, 유통 채널별 (병원, 기타) 분석, 용도별 (주의 결함 및 다동성 장애, 기면증, 기타) 분석, 고객 현황, 지역별 현황 (북미, 아시아 태평양, 유럽, 기타 지역, 미국, 캐나다, 영국, 독일, 중국) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 자료는 Astellas Pharma Inc., Azurity Pharmaceuticals Inc., Elite Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Ironshore, Jazz Pharmaceuticals Plc, KemPharm Inc., Merck and Co. Inc., Novartis AG, Pfizer 등의 기업 정보가 포함되어 있습니다.
・개요
・시장 현황
・시장 규모 예측
・과거 시장 규모
・Five Force 분석
・세계의 중추 신경계 (CNS) 자극제 시장 규모 : 유통 채널별
- 병원 채널의 시장 규모
- 기타 채널의 시장 규모
・세계의 중추 신경계 (CNS) 자극제 시장 규모 : 용도별
- 주의 결함 및 다동성 장애에 사용되는 중추 신경계 (CNS) 자극제의 시장 규모
- 기면증에 사용되는 중추 신경계 (CNS) 자극제의 시장 규모
- 기타 용도에 사용되는 중추 신경계 (CNS) 자극제의 시장 규모
・고객 현황
・지역별 현황
- 북미의 중추신경계 (CNS) 자극제 시장 규모
- 유럽의 중추신경계 (CNS) 자극제 시장 규모
- 아시아 태평양의 중추신경계 (CNS) 자극제 시장 규모
- 기타 지역의 중추신경계 (CNS) 자극제 시장 규모
- 미국의 중추신경계 (CNS) 자극제 시장 규모
- 캐나다의 중추신경계 (CNS) 자극제 시장 규모
- 영국의 중추신경계 (CNS) 자극제 시장 규모
- 독일의 중추신경계 (CNS) 자극제 시장 규모
- 중국의 중추신경계 (CNS) 자극제 시장 규모
・성장 요인/과제/동향
・기업 현황
・기업 분석
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 중추신경계 (CNS) 자극제 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 중추신경계 (CNS) 자극제 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Central Nervous System (CNS) Stimulant Drugs Market 2023-2027Technavio has been monitoring the central nervous system (CNS) stimulant drugs market and is forecast to grow by $6486.71 mn during 2022-2027, accelerating at a CAGR of 5.8% during the forecast period. Our report on the central nervous system (CNS) stimulant drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise in CNS disorders, approval of new stimulants, and increasing use of stimulants worldwide.
Technavio’s central nervous system (CNS) stimulant drugs market is segmented as below:
By Distribution Channel
• Hospitals
• Others
By Application
• Attention-deficit hyperactivity disorder
• Narcolepsy
• Others
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the increased uptake of new-generation drugs as one of the prime reasons driving the central nervous system (CNS) stimulant drugs market growth during the next few years. Also, rising demand to legalize cannabis worldwide and increasing repurposing of drugs will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the central nervous system (CNS) stimulant drugs market covers the following areas:
• Central nervous system (CNS) stimulant drugs market sizing
• Central nervous system (CNS) stimulant drugs market forecast
• Central nervous system (CNS) stimulant drugs market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading central nervous system (CNS) stimulant drugs market vendors that include Astellas Pharma Inc., Azurity Pharmaceuticals Inc., Elite Pharmaceuticals Inc., Hisamitsu Pharmaceutical Co. Inc., Ironshore, Jazz Pharmaceuticals Plc, KemPharm Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Purdue Pharma LP, Sanofi SA, Shionogi and Co. Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Tris Pharma Inc., Viatris Inc., and Thermo Fisher Scientific Inc. Also, the central nervous system (CNS) stimulant drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global central nervous system (CNS) stimulant drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global central nervous system (CNS) stimulant drugs market 2017 – 2021 ($ million)
o 4.2 Distribution channel Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospitals – Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 6.4 Others – Market size and forecast 2022-2027
o Exhibit 38: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Distribution Channel
o Exhibit 42: Market opportunity by Distribution Channel ($ million)
o Exhibit 43: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Attention-deficit hyperactivity disorder – Market size and forecast 2022-2027
o Exhibit 48: Chart on Attention-deficit hyperactivity disorder – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Attention-deficit hyperactivity disorder – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Attention-deficit hyperactivity disorder – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Attention-deficit hyperactivity disorder – Year-over-year growth 2022-2027 (%)
o 7.4 Narcolepsy – Market size and forecast 2022-2027
o Exhibit 52: Chart on Narcolepsy – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Narcolepsy – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Narcolepsy – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Narcolepsy – Year-over-year growth 2022-2027 (%)
o 7.5 Others – Market size and forecast 2022-2027
o Exhibit 56: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Application
o Exhibit 60: Market opportunity by Application ($ million)
o Exhibit 61: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share by geography 2022-2027 (%)
o Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 83: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Canada – Market size and forecast 2022-2027
o Exhibit 87: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.9 UK – Market size and forecast 2022-2027
o Exhibit 91: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 China – Market size and forecast 2022-2027
o Exhibit 99: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 103: Market opportunity by geography ($ million)
o Exhibit 104: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Azurity Pharmaceuticals Inc.
o Exhibit 111: Azurity Pharmaceuticals Inc. – Overview
o Exhibit 112: Azurity Pharmaceuticals Inc. – Product / Service
o Exhibit 113: Azurity Pharmaceuticals Inc. – Key offerings
o 12.4 Elite Pharmaceuticals Inc.
o Exhibit 114: Elite Pharmaceuticals Inc. – Overview
o Exhibit 115: Elite Pharmaceuticals Inc. – Business segments
o Exhibit 116: Elite Pharmaceuticals Inc. – Key offerings
o Exhibit 117: Elite Pharmaceuticals Inc. – Segment focus
o 12.5 Hisamitsu Pharmaceutical Co. Inc.
o Exhibit 118: Hisamitsu Pharmaceutical Co. Inc. – Overview
o Exhibit 119: Hisamitsu Pharmaceutical Co. Inc. – Product / Service
o Exhibit 120: Hisamitsu Pharmaceutical Co. Inc. – Key offerings
o 12.6 Ironshore
o Exhibit 121: Ironshore – Overview
o Exhibit 122: Ironshore – Product / Service
o Exhibit 123: Ironshore – Key offerings
o 12.7 Jazz Pharmaceuticals Plc
o Exhibit 124: Jazz Pharmaceuticals Plc – Overview
o Exhibit 125: Jazz Pharmaceuticals Plc – Product / Service
o Exhibit 126: Jazz Pharmaceuticals Plc – Key news
o Exhibit 127: Jazz Pharmaceuticals Plc – Key offerings
o 12.8 KemPharm Inc.
o Exhibit 128: KemPharm Inc. – Overview
o Exhibit 129: KemPharm Inc. – Product / Service
o Exhibit 130: KemPharm Inc. – Key offerings
o 12.9 Merck and Co. Inc.
o Exhibit 131: Merck and Co. Inc. – Overview
o Exhibit 132: Merck and Co. Inc. – Business segments
o Exhibit 133: Merck and Co. Inc. – Key news
o Exhibit 134: Merck and Co. Inc. – Key offerings
o Exhibit 135: Merck and Co. Inc. – Segment focus
o 12.10 Novartis AG
o Exhibit 136: Novartis AG – Overview
o Exhibit 137: Novartis AG – Business segments
o Exhibit 138: Novartis AG – Key offerings
o Exhibit 139: Novartis AG – Segment focus
o 12.11 Pfizer Inc.
o Exhibit 140: Pfizer Inc. – Overview
o Exhibit 141: Pfizer Inc. – Product / Service
o Exhibit 142: Pfizer Inc. – Key news
o Exhibit 143: Pfizer Inc. – Key offerings
o 12.12 Purdue Pharma LP
o Exhibit 144: Purdue Pharma LP – Overview
o Exhibit 145: Purdue Pharma LP – Product / Service
o Exhibit 146: Purdue Pharma LP – Key offerings
o 12.13 Sanofi SA
o Exhibit 147: Sanofi SA – Overview
o Exhibit 148: Sanofi SA – Business segments
o Exhibit 149: Sanofi SA – Key news
o Exhibit 150: Sanofi SA – Key offerings
o Exhibit 151: Sanofi SA – Segment focus
o 12.14 Takeda Pharmaceutical Co. Ltd.
o Exhibit 152: Takeda Pharmaceutical Co. Ltd. – Overview
o Exhibit 153: Takeda Pharmaceutical Co. Ltd. – Product / Service
o Exhibit 154: Takeda Pharmaceutical Co. Ltd. – Key news
o Exhibit 155: Takeda Pharmaceutical Co. Ltd. – Key offerings
o 12.15 Teva Pharmaceutical Industries Ltd.
o Exhibit 156: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 157: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 158: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 159: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.16 Tris Pharma Inc.
o Exhibit 161: Tris Pharma Inc. – Overview
o Exhibit 162: Tris Pharma Inc. – Product / Service
o Exhibit 163: Tris Pharma Inc. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 164: Viatris Inc. – Overview
o Exhibit 165: Viatris Inc. – Business segments
o Exhibit 166: Viatris Inc. – Key offerings
o Exhibit 167: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global central nervous system (CNS) stimulant drugs market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Distribution channel Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits31: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Distribution Channel ($ million)
Exhibits43: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits44: Chart on Application – Market share 2022-2027 (%)
Exhibits45: Data Table on Application – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Attention-deficit hyperactivity disorder – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Attention-deficit hyperactivity disorder – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Attention-deficit hyperactivity disorder – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Attention-deficit hyperactivity disorder – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Narcolepsy – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Narcolepsy – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Narcolepsy – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Narcolepsy – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Application ($ million)
Exhibits61: Data Table on Market opportunity by Application ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2022-2027 (%)
Exhibits64: Data Table on Market share by geography 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Azurity Pharmaceuticals Inc. – Overview
Exhibits112: Azurity Pharmaceuticals Inc. – Product / Service
Exhibits113: Azurity Pharmaceuticals Inc. – Key offerings
Exhibits114: Elite Pharmaceuticals Inc. – Overview
Exhibits115: Elite Pharmaceuticals Inc. – Business segments
Exhibits116: Elite Pharmaceuticals Inc. – Key offerings
Exhibits117: Elite Pharmaceuticals Inc. – Segment focus
Exhibits118: Hisamitsu Pharmaceutical Co. Inc. – Overview
Exhibits119: Hisamitsu Pharmaceutical Co. Inc. – Product / Service
Exhibits120: Hisamitsu Pharmaceutical Co. Inc. – Key offerings
Exhibits121: Ironshore – Overview
Exhibits122: Ironshore – Product / Service
Exhibits123: Ironshore – Key offerings
Exhibits124: Jazz Pharmaceuticals Plc – Overview
Exhibits125: Jazz Pharmaceuticals Plc – Product / Service
Exhibits126: Jazz Pharmaceuticals Plc – Key news
Exhibits127: Jazz Pharmaceuticals Plc – Key offerings
Exhibits128: KemPharm Inc. – Overview
Exhibits129: KemPharm Inc. – Product / Service
Exhibits130: KemPharm Inc. – Key offerings
Exhibits131: Merck and Co. Inc. – Overview
Exhibits132: Merck and Co. Inc. – Business segments
Exhibits133: Merck and Co. Inc. – Key news
Exhibits134: Merck and Co. Inc. – Key offerings
Exhibits135: Merck and Co. Inc. – Segment focus
Exhibits136: Novartis AG – Overview
Exhibits137: Novartis AG – Business segments
Exhibits138: Novartis AG – Key offerings
Exhibits139: Novartis AG – Segment focus
Exhibits140: Pfizer Inc. – Overview
Exhibits141: Pfizer Inc. – Product / Service
Exhibits142: Pfizer Inc. – Key news
Exhibits143: Pfizer Inc. – Key offerings
Exhibits144: Purdue Pharma LP – Overview
Exhibits145: Purdue Pharma LP – Product / Service
Exhibits146: Purdue Pharma LP – Key offerings
Exhibits147: Sanofi SA – Overview
Exhibits148: Sanofi SA – Business segments
Exhibits149: Sanofi SA – Key news
Exhibits150: Sanofi SA – Key offerings
Exhibits151: Sanofi SA – Segment focus
Exhibits152: Takeda Pharmaceutical Co. Ltd. – Overview
Exhibits153: Takeda Pharmaceutical Co. Ltd. – Product / Service
Exhibits154: Takeda Pharmaceutical Co. Ltd. – Key news
Exhibits155: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibits156: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits157: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits158: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits159: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits160: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits161: Tris Pharma Inc. – Overview
Exhibits162: Tris Pharma Inc. – Product / Service
Exhibits163: Tris Pharma Inc. – Key offerings
Exhibits164: Viatris Inc. – Overview
Exhibits165: Viatris Inc. – Business segments
Exhibits166: Viatris Inc. – Key offerings
Exhibits167: Viatris Inc. – Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations
|
| ※본 조사보고서 [세계의 중추 신경계 (CNS) 자극제 시장 (2023년~2027년)] (코드 : IRTNTR72695-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 중추 신경계 (CNS) 자극제 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
